Composition and method for treating rosacea and sensitive skin with free radical scavengers
AssigneeAvon Products, Inc.
InventorDmitri Ptchelintsev
Life of this patent
Estimating the term…
Abstract
A method for treating skin conditions, such as rosacea and sensitive skin, that manifest as a tendency towards flushing and blushing is provided. Also provided herein, are compositions for the treatment of rosacea and sensitive skin that are comprised of at least one antioxidant selected from the following groups of antioxidants: (a) phenolic compounds that contain at least one hydroxyl group connected directly to a benzene ring and to another unsaturated chemical grouping, (b) sulfur-containing compounds that contain at least one sulfhydryl groups or sulfur-containing compounds that contain at least one disulfide group, or (c) polyene compounds that have conjugated systems of double bonds.
Claims19
A method of treating rosacea or flushing and/or blushing associated therewith comprising topically applying to an individual in need thereof a composition comprising
- an effective amount of an antioxidant selected from the group consisting of a phenolic compound, sulfur-containing compound, polyene compound, and mixtures thereof,
- wherein said phenolic compound contains at least one hydroxyl group connected directly to a benzene ring,
- wherein said sulfur-containing compound contains at least one sulfhydryl group or at least one disulfide group, and
- wherein said polyene compound has conjugated systems of double bonds.
A composition for treating rosacea or flushing and/or blushing associated therewith comprising:
- about 2 wt % antioxidant, and about 98 wt % vehicle,
- wherein said antioxidant comprises a mixture of tocopherols, vitamin E succinate 1000 PEG, gamma oryzanol, lipoic acid, hesperetin, naringenin, silybin and acid.
A composition for treating rosacea or flushing and/or blushing associated therewith comprising:
- about 2 wt % antioxidant, and
- about 98 wt % vehicle,
- wherein said antioxidant comprises a mixture of tocopherol acetate, vitamin E succinate 1000 PEG, gamma oryzanol, carnosic acid, butylated hydroxytoluene, propyl gallate, silybin, chlorogenic acid, glabridin, and citrus bioflavonoid complex.
A method for treating rosacea or flushing and/or blushing associated therewith, comprising topically applying to an individual in need thereof a composition comprising an effective amount of an antioxidant selected from the group consisting of bioflavanoids of flavone, isoflavone or flavanol, citrus bioflavanoid complexes, ascorbic acid, ascorbic acid derivatives and cycloartenyl ferrulate.
A method for treating rosacea or flushing and/or blushing associated therewith, comprising topically applying to an individual in need thereof a composition comprising an effective amount of an antioxidant and a vehicle, wherein said antioxidant comprises a mixture of at least two compounds, each of said at least two compounds being selected from the group consisting of phenolic compounds that contain at least one hydroxyl group connected directly to a benzene ring, sulfur-containing compounds that contain at least one sulfhydryl group or at least one disulfide group, and polyene compounds that have conjugated systems of double bonds;
- and wherein the first of said at least two compounds is different than the second of said at least two compounds.
A method for treating rosacea or flushing and/or blushing associated therewith, comprising topically applying to an individual in need thereof a composition comprising an effective amount of an antioxidant and a vehicle, wherein said antioxidant comprises a mixture of at least two compounds, each of said at least two compounds being selected from the group consisting of phenolic compounds that contain at least one hydroxyl group connected directly to a benzene ring, sulfur-containing compounds that contain at least one sulfhydryl group or at least one disulfide group, and polyene compounds that have conjugated systems of double bonds;
- and wherein the first of said at least two compounds is lipophilic and the second of said at least two compounds is hydrophilic.
Dependencies are inferred from the claim text.